Pulse nav.journalClub Tendencias Explorar Preguntas Investigadores

© Synapse Social LLC, 2026Política de privacidad

⌘+K

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus | Synapse

July 18, 2001

Proteína C-reactiva, Interleucina 6 y riesgo de desarrollar diabetes mellitus tipo 2

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Niveles elevados de CRP e IL-6 predicen el desarrollo de DM tipo 2. Estos datos respaldan un posible papel de la inflamación en la diabetogénesis.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Aruna D. Pradhan (miércoles) estudió esta cuestión.

synapsesocial.com/papers/69d5740ccb7e4bf698cf4073 — DOI: https://doi.org/10.1001/jama.286.3.327

Authors

A

Aruna D. Pradhan

Preventive Cardiology

Journals

JAMA

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.· 1999 · 309 citations
The Instructive Role of Innate Immunity in the Acquired Immune Response· 1996 · 1,719 citations
The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*· 1991 · 312 citations
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein· 1994 · 1,030 citations
Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome· 1997 · 352 citations